Search Results - "Chantharaksri, Udom"

Refine Results
  1. 1

    Redox Reaction of Artemisinin with Ferrous and Ferric Ions in Aqueous Buffer by SIBMOOH, Nathawut, UDOMSANGPETCH, Rachanee, KIJJOA, Anake, CHANTHARAKSRI, Udom, MANKHETKORN, Samlee

    Published in Chemical & pharmaceutical bulletin (01-12-2001)
    “…Artemisinin, a sesquiterpene with endoperoxide bond, possesses potent antimalarial activity against the ring and late stage of chloroqine-resistant Plasmodium…”
    Get full text
    Journal Article
  2. 2

    Improvement of vascular function by chronic administration of a cyclo-oxygenase inhibitor in cholesterol-fed rabbits by Srisawat, Supath, Phivthong-ngam, Laddawal, Unchern, Supeenun, Chantharaksri, Udom, Govitrapong, Piyarat, Sanvarinda, Yupin

    “…Summary 1. Atherosclerotic cardio‐ and cerebrovascular disease is a leading cause of mortality in Western countries. Aspirin‐like drugs are widely used to…”
    Get full text
    Journal Article
  3. 3

    Effect of Artemisinin on Lipid Peroxidation and Fluidity of the Erythrocyte Membrane in Malaria by SIBMOOH, Nathawut, PIPITAPORN, Busaba, WILAIRATANA, Polrat, DANGDOUNGJAI, Jeerawan, UDOMSANGPETCH, Rachanee, LOOAREESUWAN, Sornchai, CHANTHARAKSRI, Udom

    Published in Biological & pharmaceutical bulletin (01-11-2000)
    “…The effect of artemisinin on membrane fluidity of erythrocytes was investigated using spin labeling compounds, doxyl stearic acids. The membrane fluidity of…”
    Get full text
    Journal Article
  4. 4

    Atorvastatin affects TLR4 clustering via lipid raft modulation by Chansrichavala, Praveen, Chantharaksri, Udom, Sritara, Piyamitr, Ngaosuwankul, Nathamon, Chaiyaroj, Sansanee C.

    Published in International immunopharmacology (01-08-2010)
    “…Statins, HMG-CoA reductase inhibitors, are used widely in the treatment of hypercholesterolemia. Apart from lowering lipid levels, statins have been shown to…”
    Get full text
    Journal Article
  5. 5

    Pharmacokinetics of Deferiprone in Patients with β-Thalassaemia: Impact of Splenectomy and Iron Status by Limenta, Lie Michael George, Jirasomprasert, Totsapol, Jittangprasert, Piyada, Wilairat, Prapin, Yamanont, Praveena, Chantharaksri, Udom, Fucharoen, Suthat, Morales, Noppawan Phumala

    Published in Clinical pharmacokinetics (2011)
    “…Background and Objective Iron-rich transfusions and/or a compensatory increase in iron absorption ultimately result in iron loading in patients with…”
    Get full text
    Journal Article
  6. 6

    Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study by Sutipornpalangkul, Werasak, Morales, Noppawan Phumala, Unchern, Supeenun, Sanvarinda, Yupin, Chantharaksri, Udom, Fucharoen, Suthat

    “…Beta-thalassemia/Hemoglobin E (beta-thal/Hb E) is prevalent in Thailand. The imbalance of globin chains in red blood cells is the primary cause of this anemic…”
    Get more information
    Journal Article
  7. 7

    UGT1A6 genotype‐related pharmacokinetics of deferiprone (L1) in healthy volunteers by Limenta, Lie Michael George, Jirasomprasert, Totsapol, Tankanitlert, Jeeranut, Svasti, Saovaros, Wilairat, Prapin, Chantharaksri, Udom, Fucharoen, Suthat, Morales, Noppawan Phumala

    Published in British journal of clinical pharmacology (01-06-2008)
    “…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • UGT1A6 has been proposed as the predominant isoform responsible for the glucuronidation of deferiprone. • UGT1A6*2…”
    Get full text
    Journal Article
  8. 8

    Oxidative Modification and Poor Protective Activity of HDL on LDL Oxidation in Thalassemia by Unchern, Supeenun, Laohareungpanya, Narumon, Sanvarinda, Yupin, Pattanapanyasat, Kovit, Tanratana, Pansakorn, Chantharaksri, Udom, Sibmooh, Nathawut

    Published in Lipids (01-07-2010)
    “…Oxidative modification of low-density lipoprotein (LDL) has been reported in thalassemia, which is a consequence of oxidative stress. However, the levels of…”
    Get full text
    Journal Article
  9. 9

    Pharmacokinetics of Deferiprone in Patients with [beta]-Thalassaemia by Limenta, Lie Michael George, Jirasomprasert, Totsapol, Jittangprasert, Piyada, Wilairat, Prapin, Yamanont, Praveena, Chantharaksri, Udom, Fucharoen, Suthat, Morales, Noppawan Phumala

    Published in Clinical pharmacokinetics (01-01-2011)
    “…Background and Objective: Iron-rich transfusions and/or a compensatory increase in iron absorption ultimately result in iron loading in patients with…”
    Get full text
    Journal Article
  10. 10

    Lipid fluidity at different regions in LDL and HDL of β-thalassemia/Hb E patients by Morales, Noppawan Phumala, Charlermchoung, Chalermkhwan, Luechapudiporn, Rataya, Yamanont, Paveena, Fucharoen, Suthat, Chantharaksri, Udom

    “…Atherosclerosis-related vascular complications in β-thalassemia/hemoglobin E (β-thal/Hb E) patients may result from iron induced oxidation of lipoproteins. To…”
    Get full text
    Journal Article
  11. 11

    Modification of platelet shape change parameter by oxidized lipoprotein from beta-thalassemia/Hemoglobin E by Sutipornpalangkul, Werasak, Unchern, Supeenun, Sanvarinda, Yupin, Chantharaksri, Udom, Fucharoen, Suthat

    “…Beta-thalassemia/Hemoglobin E (beta-thal/Hb E) is a congenital hemolytic anemia that is prevalent in Thailand Pulmonary arterial occlusion is the cause of…”
    Get more information
    Journal Article
  12. 12

    Modification of platelet shape change parameter by modified phospholipids in oxidized LDL by Sutipornpalangkul, Werasak, Unchen, Supeenun, Sanvarinda, Yupin, Chantharaksri, Udom

    “…It is believed that the oxidatively modified lipoproteins play a critical role in activating platelets and is a contributing factor in the etiology of a number…”
    Get more information
    Journal Article
  13. 13

    The reduction of cholesteryl linoleate in lipoproteins: an index of clinical severity in beta-thalassemia/Hb E by Luechapudiporn, Rataya, Morales, Noppawan Phumala, Fucharoen, Suthat, Chantharaksri, Udom

    Published in Clinical chemistry and laboratory medicine (01-05-2006)
    “…Oxidative modification of lipoproteins has been reported in beta-thalassemia and has been suggested to relate to atherogenesis-risk. This study focused on the…”
    Get more information
    Journal Article
  14. 14

    Association between promoter and coding region mutations of UDP-glucuronosyltransferase 1A1 and β-thalassemia/Hb E with cholelithiasis by Tankanitlert, Jeeranut, Morales, Noppawan P., Fucharoen, Pranee, Fucharoen, Suthat, Chantharaksri, Udom

    Published in European journal of haematology (01-04-2008)
    “…Background and objectives:  Cholelithiasis has been observed with high incidence in beta‐thalassemia/hemoglobin E (β‐thal/Hb E). Recent studies have shown that…”
    Get full text
    Journal Article
  15. 15

    Pharmaco/ferrokinetic-related pro-oxidant activity of deferiprone in beta-thalassemia by Jirasomprasert, Totsapol, Morales, Noppawan P, Limenta, Lie M G, Sirijaroonwong, Srisuporn, Yamanont, Paveena, Wilairat, Prapin, Fucharoen, Suthat, Chantharaksri, Udom

    Published in Free radical research (2009)
    “…The potential of free radical formation in serum of beta-thalassemia/Hb E patients receiving a single oral dose of 25 mg/kg body weight of deferiprone, a…”
    Get more information
    Journal Article
  16. 16

    Effects of combined UDP-glucuronosyltransferase (UGT) 1A128 and 1A62 on paracetamol pharmacokinetics in beta-thalassemia/HbE by Tankanitlert, Jeeranut, Morales, Noppawan Phumala, Howard, Thad A, Fucharoen, Pranee, Ware, Russell E, Fucharoen, Suthat, Chantharaksri, Udom

    Published in Pharmacology (01-01-2007)
    “…In addition to pathophysiological changes, genetic variations can alter drug pharmacokinetics in patients with thalassemia. Numerous drugs are metabolized by…”
    Get more information
    Journal Article
  17. 17

    Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of beta-thalassemia/hemoglobin E patients by Phumala Morales, Noppawan, Cherlermchoung, Chalermkhwan, Fucharoen, Suthat, Chantharaksri, Udom

    Published in Clinical chemistry and laboratory medicine (01-01-2007)
    “…Iron-induced oxidative stress may be implicated in the alteration of the lipoprotein-associated antioxidant enzymes paraoxonase 1 (PON1) and…”
    Get more information
    Journal Article
  18. 18

    Lipid fluidity at different regions in LDL and HDL of {beta}-thalassemia/Hb E patients by Morales, Noppawan Phumala, Charlermchoung, Chalermkhwan, Luechapudiporn, Rataya, Yamanont, Paveena, Fucharoen, Suthat, Chantharaksri, Udom

    “…Atherosclerosis-related vascular complications in {beta}-thalassemia/hemoglobin E ({beta}-thal/Hb E) patients may result from iron induced oxidation of…”
    Get full text
    Journal Article
  19. 19

    Hemin: a possible cause of oxidative stress in blood circulation of beta-thalassemia/hemoglobin E disease by Phumala, Noppawan, Porasuphatana, Supatra, Unchern, Supeenun, Pootrakul, Pensri, Fucharoen, Suthat, Chantharaksri, Udom

    Published in Free radical research (01-01-2003)
    “…A correlation between endogenous hemin and pro-oxidant activity was revealed in serum of beta-thalassemia/hemoglobin E disease (beta-thal/Hb E), which is the…”
    Get more information
    Journal Article
  20. 20

    The effects of vitamin E on platelet activity in β‐thalassaemia patients by Unchern, Supeenun, Laoharuangpanya, Narumol, Phumala, Noppawan, Sipankapracha, Pornpan, Pootrakul, Pensri, Fucharoen, Suthat, Wanachivanawin, Wanchai, Chantharaksri, Udom

    Published in British journal of haematology (01-11-2003)
    “…A double‐blind, crossover, placebo‐controlled study of the effect of vitamin E on platelet functions was performed on nine splenectomized and 16…”
    Get full text
    Journal Article